The presence of elemental impurities in drug substances has gained increasing attention in the pharmaceutical industry due to their potential impact on product safety and efficacy. Regulatory agencies worldwide have established guidelines and requirements to ensure the control and mitigation of elemental impurities in drug substances and products. This review article provides a comprehensive analysis of the regulatory landscape surrounding elemental impurity control, focusing on both drug substances and the broader pharmaceutical market.
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report